MFG
GOSS icon

Merit Financial Group’s Gossamer Bio GOSS Stock Holding History

Merit Financial Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
169,596
+15,155
+10% +$4.23K ﹤0.01% 2323
2026
Q1 		$50.7K Sell
154,441
-737
-0.5% -$1.16K ﹤0.01% 2059
2025
Q4 		$481K Buy
155,178
+20,490
+15% +$58.5K ﹤0.01% 1329
2025
Q3 		$354K Buy
+134,688
New +$297K ﹤0.01% 1345

Other funds holding GOSS

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WA
Waddell & Associates Memphis, Tennessee $2.02B AUM 36.49% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Merit Financial Group's GOSS Position: Q2 2026 in Review

Merit Financial Group increased its Gossamer Bio (GOSS) stake by 9.8% in Q2 2026, buying an estimated $4.23K and bringing the position to 169,596 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Merit Financial Group first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $481K in Q4 2025. 13 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Merit Financial Group held 169,596 shares of Gossamer Bio worth $27.9K as of Q2 2026.
  • Merit Financial Group bought 15,155 Gossamer Bio shares in Q2 2026, an estimated $4.23K.
  • Gossamer Bio made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2323 holding.
  • Merit Financial Group first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Merit Financial Group's Gossamer Bio position peaked at $481K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.